Navicixizumab Phase 1b has been data published in the Journal of Clinical Oncology

Mereo BioPharma's partner for the development of Navicixizumab, OncXerna Therapeutics Inc. announced that Navicixizumab Phase 1b data has been published in the Journal of Clinical Oncology.